Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed BSE that its trading window for insiders will be closed from January 1, 2026 until 48 hours after the company declares its unaudited standalone financial results for the third quarter ended December 31, 2025. The closure applies to all designated persons, designated employees, specified persons, and their immediate relatives. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015 and the company's internal code of conduct. The window is typically reopened after quarterly results are made public to ensure no insider trading takes place on price-sensitive information.
This is a standard regulatory filing with no direct impact on shareholders or stock price. It simply restricts insiders from trading the stock ahead of the Q3 FY26 results announcement expected in January 2026, and may indicate that results are forthcoming within the next few weeks.